The much anticipated World ADC Conference 2022 is a great opportunity to stay up to date with the industry trends and learn what's new in ADC. While at the conference, be sure to attend the Tech Slam as our CTDO, Greg Hermanson is one of the speakers!
Come by booth #42 to meet our team and hear how dPEG® is innovating drug development!
What Makes dPEG® Extraordinary?
Quanta BioDesign's building blocks and protected linkers enable SuperHydrophilic™ constructs and peptide modifications via our world-famous dPEG® products. Our simple-to-use products transform hydrophobic peptides into hydrophilic products. Moreover, the single molecular weight, discrete-length PEG chain (i.e., dPEG®) simplifies peptide analysis compared to dispersed PEG linkers that contain a range of PEG chain lengths and molecular weights.
Linker Architectures as Steric Auxiliaries for Altering Enzyme-Mediated Payload Realease from Bioconjugates.
Four Quanta BioDesign scientists – Matt Giese, Robert Woodman, Greg Hermanson, and Paul Davis – recently wrote an invited chapter for the book Chemical Linkers in Antibody-Drug Conjugates (ADCs), edited by Floris L. Van Delft and John M. Lambert (Royal Society of Chemistry, 2022).